Skip to main content

Jubilant Integrates PathArt Database with FDA s Microarray Analysis Platform

NEW YORK, Aug. 10 (GenomeWeb News) - Jubilant Biosys said today that it has integrated PathArt, a database of over 900 signaling and metabolic pathways curated manually from the literature, with the US Food and Drug Administration's ArrayTrack DNA microarray analysis software system.


"The integration will allow users of ArrayTrack to use the built in plug-in to ... map the results of their analysis within ArrayTrack onto the pathways in PathArt," Sreenivas Devidas, vice president of business development and strategy at Jubilant, said in a statement. "The integration will allow the scientist to view the relevant hits in diseases, physiologies, and individual pathways, and [the] prioritization of targets for further research."


The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.